Antibodies to oxidised LDL

被引:50
作者
Vaarala, O [1 ]
机构
[1] Natl Publ Hlth Inst, Dept Biochem, SF-00300 Helsinki, Finland
关键词
oxidised LDL; cardiolipin; atherosclerosis; antiphospholipid syndrome; SLE;
D O I
10.1191/096120300678828280
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In prospective studies antibodies to oxidised LDL (low density lipoprotein) have been shown to predict myocardial infarction and progression of carotid athesclerosis in non-autoimmune subjects. The antibodies to oxidised LDL are crossreactive with antiphospholipid antibodies most likely due to their binding to oxidised phospholipids. The Frequent occurrence of these antibodies and their association with arterial thrombosis in patients with SLE and antiphospholipid syndrome suggest their involvement in the development of accelerated atherosclerosis in these patients. Some in vitro studies suggest that antibodies to oxidised LDL may have an atherogenic effect by enhancing the lipid accumulation into macrophages in the atherosclerotic vessels. These antibodies can be considered as markers of the pathogenic determinants of atherosclerosis, such as enhanced lipid oxidation, proinflammatory stage and impaired vasodilatation.
引用
收藏
页码:202 / 205
页数:4
相关论文
共 36 条
[11]   Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids - Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein [J].
Horkko, S ;
Miller, E ;
Dudl, E ;
Reaven, P ;
Curtiss, LK ;
Zvaifler, NJ ;
Terkeltaub, R ;
Pierangeli, SS ;
Branch, DW ;
Palinski, W ;
Witztum, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :815-825
[12]   Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies [J].
Iuliano, L ;
Pratico, D ;
Ferro, D ;
Pittoni, V ;
Valesini, G ;
Lawson, J ;
FitzGerald, GA ;
Violi, F .
BLOOD, 1997, 90 (10) :3931-3935
[13]   THE ATHEROGENIC EFFECT OF LUPUS SERA - SYSTEMIC LUPUS ERYTHEMATOSUS-DERIVED IMMUNE-COMPLEXES STIMULATE THE ACCUMULATION OF CHOLESTEROL IN CULTURED SMOOTH-MUSCLE CELLS FROM HUMAN AORTA [J].
KABAKOV, AE ;
TERTOV, VV ;
SAENKO, VA ;
POVERENNY, AM ;
OREKHOV, AN .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 63 (03) :214-220
[14]   Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers [J].
Klouche, M ;
May, AE ;
Hemmes, M ;
Messner, M ;
Kanse, SM ;
Preissner, KT ;
Bhakdi, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :784-793
[15]   The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor [J].
LopesVirella, MF ;
Binzafar, N ;
Rackley, S ;
Takei, A ;
LaVia, M ;
Virella, G .
ATHEROSCLEROSIS, 1997, 135 (02) :161-170
[16]  
Manzi S, 1997, AM J EPIDEMIOL, V145, P408
[17]  
Matsuda J, 1996, AM J HEMATOL, V52, P114
[18]  
MATSUURA E, 1994, LUPUS, V3, P314
[19]   ANTISERA AND MONOCLONAL-ANTIBODIES SPECIFIC FOR EPITOPES GENERATED DURING OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J].
PALINSKI, W ;
YLAHERTTUALA, S ;
ROSENFELD, ME ;
BUTLER, SW ;
SOCHER, SA ;
PARTHASARATHY, S ;
CURTISS, LK ;
WITZTUM, JL .
ARTERIOSCLEROSIS, 1990, 10 (03) :325-335
[20]   ANTIBODY AGAINST OXIDIZED LOW-DENSITY-LIPOPROTEIN PREDICTING MYOCARDIAL-INFARCTION [J].
PUURUNEN, M ;
MANTTARI, M ;
MANNINEN, V ;
TENKANEN, L ;
ALFTHAN, G ;
EHNHOLM, C ;
VAARALA, O ;
AHO, K ;
PALOSUO, T .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (22) :2605-2609